文献速递外周动脉疾病

门诊环境下股总动脉斑块旋切术安全且低并发症

Common Femoral Atherectomy yields safe results and low morbidity in the outpatient setting.
PubMed 文献 · Ann Vasc Surg · 2026-10-28

术后ABI从0.59升至0.80、趾压从42升至68(均P<0.01),1年主要通畅率86%、免于MALE生存94%,90天无死亡,结论认为开放手术禁忌时该术式安全有效。

要点

  • 股总动脉斑块旋切术可在门诊环境下安全实施,90天无死亡、并发症少。
  • 术后ABI和趾压均显著改善(P<0.01),1年主要通畅率86%。
  • 适用人群为开放手术禁忌的股总动脉闭塞性疾病患者。

核心结论

  • 当开放手术在医学上被禁止时,股总动脉斑块旋切术联合球囊血管成形术可安全实施,作为独立术式或联合膝下介入均获良好临床结果。
  • 在合适的临床和影像学条件下,患者预后良好且手术并发症低,该术式可成为现代血管外科医生治疗手段的有价值补充。

主要发现

  • 45%患者为间歇性跛行,55%为慢性肢体威胁性缺血(CLTI);病变TASC分级A占4%、B占29%、C占61%、D占6%。
  • 3例同时行股浅动脉(SFA)支架置入,1例同期行股总动脉支架置入,24例(49%)在旋切部位远端接受治疗。
  • 共3例并发症:1例因脱水再入院、1例术后血肿、1例局灶性SFA夹层需延迟二次支架置入;90天内无死亡。
  • 术后平均ABI从0.59升至0.80(P<0.01),趾压从42升至68(P<0.01)。

关键数值与推荐

  • 术后ABI由0.59升至0.80、趾压由42升至68,均P<0.01。
  • 71%在末次随访报告症状改善或伤口愈合。

临床怎么用

  • 对因合并症无法耐受开放手术的股总动脉闭塞性疾病患者,可考虑门诊行斑块旋切术联合球囊血管成形术。
  • 该术式可单独实施,也可联合膝下介入,围术期并发症低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Common femoral artery (CFA) endarterectomy is considered the gold standard for the treatment of CFA disease. Some patients with CFA occlusive disease have significant comorbidities that may prevent them from undergoing open surgery. Several endovascular treatment options for the CFA, such as atherectomy, angioplasty, and stenting, are available but have not been widely adopted. This study aimed to describe our experience expanding the use of atherectomy in the outpatient setting for the treatment of CFA disease. METHODS: This is a single-institution, retrospective review of 49 CFA atherectomy procedures performed from January 2017 to November 2022 at Trinity Health Ann Arbor. Primary outcomes included primary patency at 1 year and MALE-free survival. Secondary outcomes involved changes in ankle-brachial index (ABI), toe pressures, and morbidity at 90 days. RESULTS: 49 CFA atherectomies were performed on 45 patients (73 yo ± 7 years), 45% with claudication and 55% with critical limb-threatening ischemia (CLTI). TASC classification of the treated lesions was TASC A in 4%, TASC B in 29%, TASC C in 61%, and TASC D in 6%. Three patients also underwent superficial femoral artery (SFA) stenting; one had concomitant CFA stenting, and 24 (49%) underwent treatment distal to the CFA atherectomy site. We encountered three complications: one readmission for dehydration, one postoperative hematoma, and one focal SFA dissection requiring delayed secondary stent placement. There were no deaths within 90 days. Post-procedure, the average ABI increased from 0.59 to 0.80 (P<0.01), and toe pressure rose from 42 to 68 (P<0.01). Thirty-five cases had follow-up of at least one year, showing a primary patency rate of 86% and a 94% MALE-free at one year. Additionally, 71% reported symptom improvement or wound healing at their last follow-up. CONCLUSION: When open surgery may be medically prohibited, CFA atherectomy combined with balloon angioplasty can be performed safely, yielding good clinical outcomes as a standalone procedure or with additional infrainguinal interventions. When applied in appropriate clinical and radiologic circumstances, patients experience favorable outcomes with low procedural morbidity. Due to its clinical benefits and low risk, this procedure can be a valuable addition to the modern vascular surgeon's treatment armamentarium.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Napier JA, Ayerdi JA, Heidenreich MJ, et al. Common Femoral Atherectomy yields safe results and low morbidity in the outpatient setting. Ann Vasc Surg. 2026. PMID: 42951202. doi:10.1016/j.avsg.2026.10.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。